sifrol tablet 1 mg
boehringer ingelheim singapore pte. ltd. - pramipexole 2hcl monohydrate eqv pramipexole - tablet - 1mg - pramipexole 2hcl monohydrate eqv pramipexole 1mg
sifrol extended release tablet 0.375 mg
boehringer ingelheim singapore pte. ltd. - pramipexole dihydrochloride monohydrate - tablet, extended release - 0.375mg - pramipexole dihydrochloride monohydrate 0.375mg
sifrol extended release tablet 1.5mg
boehringer ingelheim singapore pte. ltd. - pramipexole dihydrochloride monohydrate - tablet, extended release - 1.500mg - pramipexole dihydrochloride monohydrate 1.500mg
sifrol er 0.375 mg
boehringer ingelheim israel ltd. - pramipexole dihydrochloride monohydrate - tablets extended release - pramipexole dihydrochloride monohydrate 0.375 mg - pramipexole - pramipexole - treatment of signs and symptoms of idiopathic parkinson's disease, as monotherapy or in combination with levodopa.
sifrol er 0.75 mg
boehringer ingelheim israel ltd. - pramipexole dihydrochloride monohydrate - tablets extended release - pramipexole dihydrochloride monohydrate 0.75 mg - pramipexole - pramipexole - treatment of signs and symptoms of idiopathic parkinson's disease, as monotherapy or in combination with levodopa.
sifrol er 1.5 mg
boehringer ingelheim israel ltd. - pramipexole dihydrochloride monohydrate - tablets extended release - pramipexole dihydrochloride monohydrate 1.5 mg - pramipexole - pramipexole - treatment of signs and symptoms of idiopathic parkinson's disease, as monotherapy or in combination with levodopa.
spiolto respimat 2.5 microgram/2.5 microgram, inhalation solution
boehringer ingelheim international gmbh - tiotropium; olodaterol - inhalation solution - 2.5 µg/2.5 microgram(s) - anticholinergics; anticholinergics - drugs for obstructive airway diseases, adrenergics in combination with anticholinergics - it is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).
pradaxa 150
boehringer ingelheim israel ltd. - dabigatran etexilate as mesilate - capsules - dabigatran etexilate as mesilate 150 mg - dabigatran etexilate - prevention of stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation.treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults.
pradaxa 150
boehringer ingelheim israel ltd. - dabigatran etexilate as mesilate - capsules - dabigatran etexilate as mesilate 150 mg - dabigatran etexilate - prevention of stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation.treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults.
pradaxa 75mg hard capsules
boehringer ingelheim singapore pte. ltd. - dabigatran etexilate mesilate 86.48mg eqv dabigatran etexilate - capsule - 75 mg - dabigatran etexilate mesilate 86.48mg eqv dabigatran etexilate 75 mg